Reported cases of measles, per unit of GDP by country
Reported cases of measles divided by GDP (current US$), matched on country and year. Neither publisher issues this ratio as a series; it is computed here from both.
Countries reporting
200
Highest
0 Cases per US$ of GDP
Democratic Republic of Congo
Lowest
0 Cases per US$ of GDP
Samoa
Median
0 Cases per US$ of GDP
Years covered
51
1974–2024
Data points
8,557
What the numbers show
Reported cases of measles, per unit of GDP is currently reported for 200 countries. The highest value is 0 Cases per US$ of GDP in Democratic Republic of Congo; the lowest is 0 Cases per US$ of GDP in Samoa.
The median across all reporting countries is 0 Cases per US$ of GDP, and the mean is 0 Cases per US$ of GDP.
Over the past decade 68 countries rose and 59 fell. The largest increase was in Uzbekistan (up 196,831.0%), and the largest decrease in Brunei (down 100.0%).
Reported cases of measles, per unit of GDP: full country ranking
| # | Country | Latest | Year | 10-year change | Trend |
|---|---|---|---|---|---|
| 1 | Democratic Republic of Congo | 0 Cases per US$ of GDP | 2024 | up 368.1% | volatile |
| 2 | Burundi | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 3 | Kyrgyzstan | 0 Cases per US$ of GDP | 2024 | up 1,759.5% | volatile |
| 4 | Afghanistan | 0 Cases per US$ of GDP | 2024 | up 2,189.2% | volatile |
| 5 | Yemen | 0 Cases per US$ of GDP | 2018 | up 189,219.0% | volatile |
| 6 | Chad | 0 Cases per US$ of GDP | 2024 | up 398.8% | volatile |
| 7 | Bosnia and Herzegovina | 0 Cases per US$ of GDP | 2024 | up 65.5% | volatile |
| 8 | Azerbaijan | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 9 | Liberia | 0 Cases per US$ of GDP | 2024 | up 1,990.3% | volatile |
| 10 | Ethiopia | 0 Cases per US$ of GDP | 2024 | down 9.5% | volatile |
| 11 | Burkina Faso | 0 Cases per US$ of GDP | 2024 | up 672.5% | volatile |
| 12 | Uzbekistan | 0 Cases per US$ of GDP | 2024 | up 196,831.0% | volatile |
| 13 | Zimbabwe | 0 Cases per US$ of GDP | 2023 | — | volatile |
| 14 | Somalia | 0 Cases per US$ of GDP | 2024 | down 92.8% | volatile |
| 15 | Niger | 0 Cases per US$ of GDP | 2024 | up 13.9% | volatile |
| 16 | Iraq | 0 Cases per US$ of GDP | 2024 | up 1,915.3% | volatile |
| 17 | Mauritania | 0 Cases per US$ of GDP | 2024 | up 4,708.2% | volatile |
| 18 | Kazakhstan | 0 Cases per US$ of GDP | 2024 | up 6,560.8% | volatile |
| 19 | Malawi | 0 Cases per US$ of GDP | 2024 | up 24,745.8% | volatile |
| 20 | South Sudan | 0 Cases per US$ of GDP | 2015 | — | volatile |
| 21 | Romania | 0 Cases per US$ of GDP | 2024 | up 22,468.1% | volatile |
| 22 | Pakistan | 0 Cases per US$ of GDP | 2024 | up 1,216.7% | volatile |
| 23 | Nigeria | 0 Cases per US$ of GDP | 2024 | up 398.0% | volatile |
| 24 | Mozambique | 0 Cases per US$ of GDP | 2024 | up 10,760.5% | volatile |
| 25 | Central African Republic | 0 Cases per US$ of GDP | 2024 | down 59.0% | volatile |
| 26 | Uganda | 0 Cases per US$ of GDP | 2024 | up 320.0% | volatile |
| 27 | Benin | 0 Cases per US$ of GDP | 2024 | down 38.2% | volatile |
| 28 | Equatorial Guinea | 0 Cases per US$ of GDP | 2024 | up 5,748.5% | volatile |
| 29 | Togo | 0 Cases per US$ of GDP | 2024 | down 63.3% | volatile |
| 30 | Congo | 0 Cases per US$ of GDP | 2024 | up 675.5% | volatile |
| 31 | Sudan | 0 Cases per US$ of GDP | 2024 | up 97.2% | volatile |
| 32 | Ghana | 0 Cases per US$ of GDP | 2024 | up 929.2% | volatile |
| 33 | Eritrea | 0 Cases per US$ of GDP | 2011 | down 91.4% | volatile |
| 34 | Guinea | 0 Cases per US$ of GDP | 2024 | up 15.7% | volatile |
| 35 | Armenia | 0 Cases per US$ of GDP | 2024 | up 1,830.2% | volatile |
| 36 | Cote d'Ivoire | 0 Cases per US$ of GDP | 2024 | up 1,999.2% | volatile |
| 37 | Sierra Leone | 0 Cases per US$ of GDP | 2024 | down 85.9% | volatile |
| 38 | Vietnam | 0 Cases per US$ of GDP | 2024 | down 74.4% | volatile |
| 39 | Cameroon | 0 Cases per US$ of GDP | 2024 | down 29.1% | volatile |
| 40 | Thailand | 0 Cases per US$ of GDP | 2024 | up 146.6% | volatile |
| 41 | Senegal | 0 Cases per US$ of GDP | 2024 | up 853.9% | volatile |
| 42 | Djibouti | 0 Cases per US$ of GDP | 2024 | up 5.5% | volatile |
| 43 | Cambodia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 44 | Mali | 0 Cases per US$ of GDP | 2024 | down 19.4% | volatile |
| 45 | Tanzania | 0 Cases per US$ of GDP | 2024 | up 611.2% | volatile |
| 46 | Moldova | 0 Cases per US$ of GDP | 2024 | up 5,477.2% | volatile |
| 47 | Zambia | 0 Cases per US$ of GDP | 2024 | up 3,463.5% | volatile |
| 48 | Comoros | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 49 | Russia | 0 Cases per US$ of GDP | 2024 | up 348.9% | volatile |
| 50 | Georgia | 0 Cases per US$ of GDP | 2024 | down 94.2% | volatile |
| 51 | Serbia | 0 Cases per US$ of GDP | 2024 | up 1,214.3% | volatile |
| 52 | Belarus | 0 Cases per US$ of GDP | 2024 | up 1,081.4% | volatile |
| 53 | Syria | 0 Cases per US$ of GDP | 2022 | up 2,937.2% | volatile |
| 54 | Malaysia | 0 Cases per US$ of GDP | 2024 | up 1,273.5% | volatile |
| 55 | Philippines | 0 Cases per US$ of GDP | 2024 | down 95.8% | volatile |
| 56 | Albania | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 57 | Angola | 0 Cases per US$ of GDP | 2024 | down 92.1% | volatile |
| 58 | Madagascar | 0 Cases per US$ of GDP | 2024 | up 2,367.7% | volatile |
| 59 | Fiji | 0 Cases per US$ of GDP | 2019 | up 1,403.8% | volatile |
| 60 | India | 0 Cases per US$ of GDP | 2024 | down 62.1% | volatile |
| 61 | Indonesia | 0 Cases per US$ of GDP | 2024 | down 68.8% | volatile |
| 62 | Turkey | 0 Cases per US$ of GDP | 2023 | down 42.1% | volatile |
| 63 | Kenya | 0 Cases per US$ of GDP | 2024 | down 15.9% | volatile |
| 64 | Libya | 0 Cases per US$ of GDP | 2024 | down 34.2% | volatile |
| 65 | Montenegro | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 66 | Morocco | 0 Cases per US$ of GDP | 2018 | down 73.5% | volatile |
| 67 | Rwanda | 0 Cases per US$ of GDP | 2024 | up 185.1% | volatile |
| 68 | Gambia | 0 Cases per US$ of GDP | 2024 | up 309.0% | volatile |
| 69 | Sri Lanka | 0 Cases per US$ of GDP | 2024 | down 85.4% | volatile |
| 70 | Lebanon | 0 Cases per US$ of GDP | 2024 | up 22.4% | volatile |
| 71 | Nepal | 0 Cases per US$ of GDP | 2024 | down 95.4% | volatile |
| 72 | South Africa | 0 Cases per US$ of GDP | 2024 | up 1,240.5% | volatile |
| 73 | Ukraine | 0 Cases per US$ of GDP | 2024 | up 96.7% | volatile |
| 74 | Micronesia (country) | 0 Cases per US$ of GDP | 2023 | — | volatile |
| 75 | Algeria | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 76 | Gabon | 0 Cases per US$ of GDP | 2024 | down 15.5% | volatile |
| 77 | Papua New Guinea | 0 Cases per US$ of GDP | 2024 | down 98.5% | volatile |
| 78 | Turks and Caicos Islands | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 79 | Namibia | 0 Cases per US$ of GDP | 2024 | down 97.1% | volatile |
| 80 | East Timor | 0 Cases per US$ of GDP | 2024 | down 96.7% | volatile |
| 81 | Austria | 0 Cases per US$ of GDP | 2024 | up 279.9% | volatile |
| 82 | United Arab Emirates | 0 Cases per US$ of GDP | 2024 | up 25.0% | volatile |
| 83 | Saudi Arabia | 0 Cases per US$ of GDP | 2024 | up 413.5% | volatile |
| 84 | Iran | 0 Cases per US$ of GDP | 2024 | up 341.2% | volatile |
| 85 | United Kingdom | 0 Cases per US$ of GDP | 2024 | up 2,050.6% | volatile |
| 86 | Seychelles | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 87 | Lesotho | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 88 | Belgium | 0 Cases per US$ of GDP | 2024 | up 502.5% | volatile |
| 89 | Cyprus | 0 Cases per US$ of GDP | 2024 | up 66.6% | volatile |
| 90 | Bangladesh | 0 Cases per US$ of GDP | 2024 | down 67.2% | volatile |
| 91 | Mongolia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 92 | Italy | 0 Cases per US$ of GDP | 2024 | up 408.9% | volatile |
| 93 | Myanmar | 0 Cases per US$ of GDP | 2024 | down 78.2% | volatile |
| 94 | Malta | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 95 | Croatia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 96 | Lithuania | 0 Cases per US$ of GDP | 2024 | up 54.1% | volatile |
| 97 | Ireland | 0 Cases per US$ of GDP | 2024 | up 174.4% | volatile |
| 98 | Tunisia | 0 Cases per US$ of GDP | 2024 | up 4.3% | volatile |
| 99 | Poland | 0 Cases per US$ of GDP | 2024 | up 82.8% | volatile |
| 100 | Maldives | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 101 | Qatar | 0 Cases per US$ of GDP | 2024 | up 14.0% | volatile |
| 102 | Jordan | 0 Cases per US$ of GDP | 2024 | down 51.6% | volatile |
| 103 | Bulgaria | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 104 | Egypt | 0 Cases per US$ of GDP | 2024 | down 94.6% | volatile |
| 105 | Slovenia | 0 Cases per US$ of GDP | 2024 | down 77.8% | volatile |
| 106 | Bermuda | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 107 | Monaco | 0 Cases per US$ of GDP | 2024 | down 79.4% | volatile |
| 108 | Netherlands | 0 Cases per US$ of GDP | 2024 | up 7.2% | volatile |
| 109 | Palestine | 0 Cases per US$ of GDP | 2023 | up 55.9% | volatile |
| 110 | Botswana | 0 Cases per US$ of GDP | 2024 | up 140.6% | volatile |
| 111 | Greece | 0 Cases per US$ of GDP | 2024 | up 3,368.9% | volatile |
| 112 | Germany | 0 Cases per US$ of GDP | 2024 | up 23.2% | volatile |
| 113 | Spain | 0 Cases per US$ of GDP | 2024 | up 17.9% | volatile |
| 114 | Oman | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 115 | North Macedonia | 0 Cases per US$ of GDP | 2024 | down 98.8% | volatile |
| 116 | Portugal | 0 Cases per US$ of GDP | 2024 | up 2,429.4% | volatile |
| 117 | Czechia | 0 Cases per US$ of GDP | 2024 | down 90.4% | volatile |
| 118 | Switzerland | 0 Cases per US$ of GDP | 2024 | up 222.3% | volatile |
| 119 | Estonia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 120 | Hungary | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 121 | Bolivia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 122 | China | 0 Cases per US$ of GDP | 2024 | down 98.6% | volatile |
| 123 | Canada | 0 Cases per US$ of GDP | 2024 | down 72.0% | volatile |
| 124 | Sweden | 0 Cases per US$ of GDP | 2024 | up 39.6% | volatile |
| 125 | Laos | 0 Cases per US$ of GDP | 2024 | down 99.8% | volatile |
| 126 | Iceland | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 127 | Denmark | 0 Cases per US$ of GDP | 2024 | down 23.0% | volatile |
| 128 | Kuwait | 0 Cases per US$ of GDP | 2024 | down 87.1% | volatile |
| 129 | Bahrain | 0 Cases per US$ of GDP | 2024 | down 96.8% | volatile |
| 130 | France | 0 Cases per US$ of GDP | 2023 | down 60.4% | volatile |
| 131 | Australia | 0 Cases per US$ of GDP | 2024 | down 85.9% | volatile |
| 132 | Luxembourg | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 133 | Slovakia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 134 | South Korea | 0 Cases per US$ of GDP | 2024 | down 90.8% | volatile |
| 135 | Hong Kong | 0 Cases per US$ of GDP | 2024 | down 87.2% | volatile |
| 136 | Singapore | 0 Cases per US$ of GDP | 2024 | down 95.3% | volatile |
| 137 | Norway | 0 Cases per US$ of GDP | 2024 | up 243.3% | volatile |
| 138 | Japan | 0 Cases per US$ of GDP | 2024 | down 88.4% | volatile |
| 139 | Peru | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 140 | Finland | 0 Cases per US$ of GDP | 2024 | down 9.5% | volatile |
| 141 | United States | 0 Cases per US$ of GDP | 2023 | down 60.7% | volatile |
| 142 | New Zealand | 0 Cases per US$ of GDP | 2024 | down 99.7% | volatile |
| 143 | Mexico | 0 Cases per US$ of GDP | 2024 | up 73.9% | volatile |
| 144 | Brazil | 0 Cases per US$ of GDP | 2024 | down 99.4% | volatile |
| 145 | Aruba | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Andorra | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Argentina | 0 Cases per US$ of GDP | 2023 | — | volatile |
| 145 | Antigua and Barbuda | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Bahamas | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Belize | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Barbados | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Brunei | 0 Cases per US$ of GDP | 2024 | down 100.0% | volatile |
| 145 | Bhutan | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Chile | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Colombia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Cape Verde | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Costa Rica | 0 Cases per US$ of GDP | 2024 | down 100.0% | volatile |
| 145 | Cuba | 0 Cases per US$ of GDP | 2020 | — | volatile |
| 145 | Dominica | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Dominican Republic | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Ecuador | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Guinea-Bissau | 0 Cases per US$ of GDP | 2024 | down 100.0% | volatile |
| 145 | Grenada | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Guatemala | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Guam | 0 Cases per US$ of GDP | 2019 | — | volatile |
| 145 | Guyana | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Honduras | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Haiti | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Israel | 0 Cases per US$ of GDP | 2022 | down 100.0% | volatile |
| 145 | Jamaica | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Kiribati | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Saint Kitts and Nevis | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Saint Lucia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Latvia | 0 Cases per US$ of GDP | 2024 | down 100.0% | volatile |
| 145 | Macao | 0 Cases per US$ of GDP | 2024 | down 100.0% | volatile |
| 145 | Marshall Islands | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Mauritius | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | New Caledonia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Nicaragua | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Nauru | 0 Cases per US$ of GDP | 2024 | down 100.0% | volatile |
| 145 | Panama | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Palau | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Paraguay | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | French Polynesia | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Solomon Islands | 0 Cases per US$ of GDP | 2023 | — | volatile |
| 145 | El Salvador | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | San Marino | 0 Cases per US$ of GDP | 2023 | down 100.0% | volatile |
| 145 | Sao Tome and Principe | 0 Cases per US$ of GDP | 2021 | — | volatile |
| 145 | Suriname | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Eswatini | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Tajikistan | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Turkmenistan | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Tonga | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Trinidad and Tobago | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Tuvalu | 0 Cases per US$ of GDP | 2019 | — | volatile |
| 145 | Uruguay | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Saint Vincent and the Grenadines | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Venezuela | 0 Cases per US$ of GDP | 2024 | — | volatile |
| 145 | Vanuatu | 0 Cases per US$ of GDP | 2024 | down 100.0% | volatile |
| 145 | Samoa | 0 Cases per US$ of GDP | 2024 | down 100.0% | volatile |
How this figure is calculated
Reported cases of measles divided by GDP (current US$), matched on country and year. Neither publisher issues this ratio as a series; it is computed here from both.
Reported cases of measles ÷ GDP (current US$)
Computed from
- Reported cases of measles World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data
- GDP Country official statistics, National Statistical Organizations and/or Central Banks
Statizoid computes this series; the underlying measurements belong to the publishers named above. The arithmetic is applied to every country and year where both inputs report, and nothing is estimated unless the page says so.
About this data
Reported cases of measles divided by GDP (current US$), matched on country and year. Neither publisher issues this ratio as a series; it is computed here from both.